
Add us as your preferred source on Google to see more of our content in Search.
The UK will offer its world-leading genomics expertise to identify new variants of the virus that causes COVID-19 to countries who do not have the resources to do so.
Countries will be offered UK capacity to analyse new strains of the virus through the launch of the New Variant Assessment Platform which will be led by Public Health England (PHE) working with NHS Test and Trace and academic partners as well as the World Health Organization’s SARS-CoV-2 Global Laboratory Working Group. This supports the Prime Minister’s 5-point plan, as outlined at the UN General Assembly (UNGA) last year, to protect humanity from another pandemic through a shared approach to global health security.
In due course, it will be led by the National Institute for Health Protection (NIHP) and will involve PHE laboratories and staff as well as academic partner capabilities.
They will be working directly on samples provided from abroad or will provide expert advice and support remotely where the partner country already has some capabilities in this area but requests further assistance. The offer could include training and resources as well as personnel and equipment.
Countries will be able to apply for assistance by contacting the World Health Organization where an existing channel does not already exist with the UK.
This vital work will combat the spread of coronavirus by identifying more COVID-19 variants around the world to keep the global community one step ahead of any mutations.
“This pandemic has shown that the foundations of so many of the exciting experiences that make life worth living are contingent not just on our health, or the health of our neighbours, but the health of people across the world. Our New Variant Assessment Platform will help us better understand this virus and how it spreads and will also boost global capacity to understand coronavirus so we’re all better prepared for whatever lies ahead,” said Health and Social Care Secretary Matt Hancock.
The UK has carried out more than half of all SARS-CoV-2 genome sequences submitted to the global database, and this capability helped PHE’s scientists identify the variant in Kent, informing new measures to tackle the spread of the virus.